J. Dunst, R. Sauer, and K. Schrott, Organ-sparing treatment of advanced bladder cancer: A 10-year experience, International Journal of Radiation Oncology*Biology*Physics, vol.30, issue.2, pp.261-266, 1994.
DOI : 10.1016/0360-3016(94)90003-5

W. Tester, A. Porter, and S. Asbell, Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of rtog protocol 85-12, International Journal of Radiation Oncology*Biology*Physics, vol.25, issue.5
DOI : 10.1016/0360-3016(93)90306-G

D. Kaufman, K. Winter, and W. Shipley, The Initial Results in Muscle-Invading Bladder Cancer of RTOG 95-06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5-Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial Response, The Oncologist, vol.5, issue.6, pp.471-476, 2000.
DOI : 10.1634/theoncologist.5-6-471

M. Housset, C. Maulard, and Y. Chretien, Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study., Journal of Clinical Oncology, vol.11, issue.11, pp.2150-2157, 1993.
DOI : 10.1200/JCO.1993.11.11.2150

C. Rödel, G. Grabenbauer, and R. Kühn, Combined-Modality Treatment and Selective Organ Preservation in Invasive Bladder Cancer: Long-Term Results, Journal of Clinical Oncology, vol.20, issue.14, pp.3061-3071, 2002.
DOI : 10.1200/JCO.2002.11.027

O. Ott, C. Rödel, and C. Weiss, Radiochemotherapy for Bladder Cancer, Clinical Oncology, vol.21, issue.7, pp.557-565, 2009.
DOI : 10.1016/j.clon.2009.05.005

H. Von-der-maase, L. Sengelov, and J. Roberts, Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer, Journal of Clinical Oncology, vol.23, issue.21, pp.4602-4608, 2005.
DOI : 10.1200/JCO.2005.07.757

D. Kaufman, W. Shipley, and A. Feldman, Bladder cancer, The Lancet, vol.374, issue.9685, pp.239-249, 2009.
DOI : 10.1016/S0140-6736(09)60491-8

D. Shewach and T. Lawrence, Radiosensitization of human solid tumor cell lines with gemcitabine, Semin Oncol, vol.23, pp.65-71, 1996.

D. Azria, W. Jacot, and P. Prost, Gemcitabine and ionizing radiations: radiosensitization or radio-chemotherapy combination, Bull Cancer, vol.89, pp.369-379, 2002.

V. Sangar, R. Cowan, and G. Margison, An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines, British Journal of Cancer, vol.90, issue.2, pp.542-548, 2004.
DOI : 10.1038/sj.bjc.6601538

F. Huguet, N. Girard, and C. Guerche, Chemoradiotherapy in the Management of Locally Advanced Pancreatic Carcinoma: A Qualitative Systematic Review, Journal of Clinical Oncology, vol.27, issue.13, pp.2269-2277, 2009.
DOI : 10.1200/JCO.2008.19.7921

N. Girard, F. Mornex, and J. Douillard, Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial, Lung Cancer, vol.69, issue.1, pp.86-93, 2010.
DOI : 10.1016/j.lungcan.2009.10.003
URL : https://hal.archives-ouvertes.fr/hal-00539239

D. Shewach, T. Hahn, and E. Chang, Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells, Cancer Res, vol.54, pp.3218-3223, 1994.

T. Lawrence, E. Chang, and T. Hahn, Radiosensitization of pancreatic cancer cells by 2???,2???-difluoro-2???-deoxycytidine, International Journal of Radiation Oncology*Biology*Physics, vol.34, issue.4, pp.867-872, 1996.
DOI : 10.1016/0360-3016(95)02134-5

T. Lawrence, E. Chang, and T. Hahn, Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2',2'-difluoro-2'-deoxycytidine (Gemcitabine)

E. Kent, H. Sandler, and J. Montie, Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I Trial, Journal of Clinical Oncology, vol.22, issue.13, pp.2540-2545, 2004.
DOI : 10.1200/JCO.2004.10.070

O. Caffo, G. Fellin, and U. Graffer, Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer, International Journal of Radiation Oncology*Biology*Physics, vol.57, issue.5, pp.1310-1316, 2003.
DOI : 10.1016/S0360-3016(03)00763-6

A. Choudhury, R. Swindell, and J. Logue, Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer, Journal of Clinical Oncology, vol.29, issue.6, pp.733-741, 2011.
DOI : 10.1200/JCO.2010.31.5721

K. Oh, D. Soto, and D. Smith, Combined-Modality Therapy With Gemcitabine and Radiation Therapy as a Bladder Preservation Strategy: Long-Term Results of a Phase I Trial, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.2, pp.511-517, 2009.
DOI : 10.1016/j.ijrobp.2008.08.021

T. Mitin, D. Hunt, and W. Shipley, Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial, The Lancet Oncology, vol.14, issue.9, pp.863-872, 2013.
DOI : 10.1016/S1470-2045(13)70255-9

T. Tarin, N. Power, and B. Ehdaie, Lymph Node???Positive Bladder Cancer Treated With Radical Cystectomy and Lymphadenectomy: Effect of the Level of Node Positivity, European Urology, vol.61, issue.5, pp.1025-1030, 2012.
DOI : 10.1016/j.eururo.2012.01.049

K. Borut and Z. Lijana, Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer, Radiotherapy and Oncology, vol.102, issue.3, pp.412-415, 2012.
DOI : 10.1016/j.radonc.2011.07.026

O. Caffo, G. Fellin, and U. Graffer, Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer, Cancer, vol.74, issue.5 suppl 10, pp.1190-1196, 2011.
DOI : 10.1002/cncr.25667

V. Sangar, C. Mcbain, and J. Lyons, Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.2, pp.420-425, 2005.
DOI : 10.1016/j.ijrobp.2004.05.074